BWA
RDY icon

Basecamp Wealth Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Basecamp Wealth Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Buy
24,573
+1,200
+5% +$16.2K 0.07% 170
2026
Q1 		$324K Sell
23,373
-1,691
-7% -$23.5K 0.07% 178
2025
Q4 		$352K Buy
+25,064
New +$352K 0.08% 160

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Basecamp Wealth Advisors's RDY Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Dr. Reddy's Laboratories (RDY) stake by 5.1% in Q2 2026, buying an estimated $16.2K and bringing the position to 24,573 shares worth $356K. The position accounts for 0.07% of the portfolio, ranked #170.

Basecamp Wealth Advisors first reported a position in RDY in Q4 2025 and has held it in 3 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Basecamp Wealth Advisors held 24,573 shares of Dr. Reddy's Laboratories worth $356K as of Q2 2026.
  • Basecamp Wealth Advisors bought 1,200 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $16.2K.
  • Dr. Reddy's Laboratories made up 0.07% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #170 holding.
  • Basecamp Wealth Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2025 and has held it in 3 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.